Open an account

Moolec Science SA

MLEC · NASDAQ

$1.72+$0.035 (+2.08%)TodayMarket closed ·
Prev close $1.69

About MLEC

Moolec Science SA engages in the development and production of science-based food ingredients. The firm operates an integrated platform encompassing research & development (R&D), manufacturing, and regulatory capabilities that span from molecular design to validation in both fermenter and field environments. The company operates across the United States, Europe, and South America. The firm advances its molecular farming programs in crops such as soy and safflower to produce proteins and lipids with animal-like functionality and plant-based cost structures. The company is developing a precision fermentation facility in Finland, under the SynBio Powerlabs brand, which will be dedicated to producing target proteins, enzymes, and other biomolecules using optimized microbial and cellular systems. Its product portfolio includes GLASO, PIGGY SOOY, VALORASOY, and MYCOFOOD. Its GLASO, a safflower-derived oil rich in functional lipids, is being used in formulations for small-animal feed.

Employees
52
Headquarters
George Town
Listed
Mar 1, 2023
Sector
Consumer Staples
Industry
Food Products
Website
moolecscience.com

MLEC key statistics

Market cap
1.25M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
84.41K
Volume
8.26K
Open price
$1.66
High today
$1.74
Low today
$1.61
52 Week high
$23.22
52 Week low
$1.48

Moolec Science SA (MLEC) at a glance

Moolec Science SA (MLEC) last traded at $1.72, with a market cap of 1.25M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $1.61 and $1.74. The current price is 7.2% above the day's low and 1.1% below its high.

Volume so far is 8.26K shares, below the average of 84.41K shares a day.

Over the past year Moolec Science SA has ranged from $1.48 to $23.22, and now sits 1% of the way up that range.

Moolec Science SA met or beat analyst EPS estimates in 6 of the last 7 quarters. In Q2 FY25 it reported -$9.00 per share against an estimate of -$9.18.

MLEC earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 6 of the last 7 quarters, by 30.2% on average.

  1. Q4 FY23: reported -$4.50 per share against an estimate of -$16.83
  2. Q1 FY24: reported -$6.00 per share against an estimate of -$6.12
  3. Q2 FY24: reported -$7.50 per share against an estimate of -$10.71
  4. Q3 FY24: reported -$6.00 per share against an estimate of -$10.71
  5. Q4 FY24: reported -$10.50 per share against an estimate of -$9.18
  6. Q1 FY25: reported -$7.50 per share against an estimate of -$10.71
  7. Q2 FY25: reported -$9.00 per share against an estimate of -$9.18

MLEC news

  • 12 Consumer Staples Stocks Moving In Monday's After-Market Session

  • 12 Consumer Staples Stocks Moving In Friday's Pre-Market Session

  • Avi Kapoor

    Gold Gains Over 1%; US Inflation Rate Falls To 2.4%

  • Avi Kapoor

    US Stocks Edge Lower; Advance Auto Parts Posts Upbeat Earnings

  • 12 Consumer Staples Stocks Moving In Thursday's After-Market Session

  • Press releaseACCESSWIRE

    Moolec Has Received USDA Approval for the First Genetically Modified Pea in History

  • 12 Consumer Staples Stocks Moving In Tuesday's After-Market Session

  • Press releaseACCESSWIRE

    Moolec Science Presents Fiscal Year 2024 Annual Business Update

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.